CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.36
+0.01 (0.19%)
At close: Sep 17, 2025, 4:00 PM EDT
5.34
-0.02 (-0.37%)
After-hours: Sep 17, 2025, 6:28 PM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $1.21 billion as of September 17, 2025. Its market cap has increased by 71.35% in one year.
Market Cap
1.21B
Enterprise Value
788.05M
1-Year Change
71.35%
Ranking
Category
Stock Price
$5.36
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.21B, a decrease of -87.73%. That is a compound annual growth rate of -33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 1.21B | 57.79% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
| Aug 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |